Your browser doesn't support javascript.
loading
Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study.
Farooqui, Maryam; Hassali, Mohamed Azmi; Shatar, Aishah Knight Abdul; Farooqui, Muhammad Aslam; Saleem, Fahad; Haq, Noman Ul; Othman, Che Noriah.
Afiliación
  • Farooqui M; Faculty of Pharmacy, Universiti Teknologi MARA, Kepala Batas, Penang, Malaysia.
  • Hassali MA; Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Shatar AK; Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Penang, Malaysia.
  • Farooqui MA; Department of Medicine, Allianze University College of Medical Sciences, Kepala Batas, Penang, Malaysia.
  • Saleem F; Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Haq NU; Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Othman CN; Faculty of Pharmacy, Universiti Teknologi MARA, Kepala Batas, Penang, Malaysia.
J Tradit Complement Med ; 6(4): 321-326, 2016 Oct.
Article en En | MEDLINE | ID: mdl-27774413
The use of Complementary and Alternative Medicine (CAM; bǔ chong yǔ tì dài yi xué) has been rapidly increasing among cancer patients. However, this pervasiveness is still largely unexplored among Malaysian cancer patients. The current study aimed to evaluate the patterns of CAM use among cancer patients from a local hospital in Malaysia. In addition, the study focused on the information-seeking behavior and CAM use disclosure to doctors. Of 393 patients, 184 (46.1%) had used CAM for their cancers. CAM usage was significantly associated with gender (p = 0.021), level of education (p = 0.001), employment status (p = 0.02), and monthly income (p < 0.001). Among frequently used CAM were nutritional supplements (n = 77, 41.8%), natural products (n = 74, 40.2%), and multivitamin (n = 62, 33.6%). Friends and family members were the most common source of CAM information (n = 139, 75.5%). Seventy-nine (43%) reported to disclose their CAM use to the health care providers. The most common (n = 63, 34.2%) reason of nondisclosure was "it is not important to discuss it with oncologist." This study confirmed that CAM use is common among Malaysian cancer patients, thus highlighting a greater need for patient education regarding CAM therapies and their potential interactions with conventional therapies. Although some types of CAM therapies may help patients to cope with emotional distress and improve quality of life, CAM, with no proven efficacy, may pose dangers to patients' health due to interactions with conventional therapies. Doctors and other health care providers including nurses and pharmacists should engage cancer patients in an open nonjudgmental dialog to ascertain CAM use disclosure to their health care providers.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: J Tradit Complement Med Año: 2016 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: J Tradit Complement Med Año: 2016 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Países Bajos